J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
Berenberg Bank Sticks to Their Buy Rating for GlaxoSmithKline (GSK)
Cautious Outlook on GlaxoSmithKline: Sell Rating Due to Pipeline and Financial Challenges
TD Cowen Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
Barclays Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Deutsche Bank Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
J.P. Morgan Remains a Sell on GlaxoSmithKline (GSK)
Berenberg Bank Keeps Their Buy Rating on GlaxoSmithKline (GSK)
Berenberg Bank Sticks to Its Buy Rating for GlaxoSmithKline (GSK)
Optimistic Buy Rating for GlaxoSmithKline: Undervalued Stock With Promising Growth Prospects
Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK) Was Downgraded to a Hold Rating at Jefferies
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK) Gets a Sell From J.P. Morgan
Graham Parry Recommends Sell Rating for GlaxoSmithKline Due to Concerns Over Arexvy Vaccine Efficacy and Safety
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GB:GSK), Gritstone Oncology (GRTS) and Immutep (IMMP)
GlaxoSmithKline (GSK) Receives a Hold From Goldman Sachs
J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
No Data